Research publications
Results
you
can trust
Rigorous scientific investigation is pivotal to our business. Below is a selection of peer-reviewed publications attesting to the bioactive properties of Maritech® fucoidan extracts.
Modulation of Gene Expression in a Sterile Atopic Dermatitis Model and Inhibition of Staphylococcus aureus Adhesion by Fucoidan, Dermatopathology, 2021
Maritech® fucoidan may be a useful topical agent to assist in the future management of atopic dermatitis. + full article
Oral fucoidan improves muscle size and strength in mice, Physiological Reports, 2021
Findings suggest an important influence of Maritech® fucoidan on skeletal muscle physiology. + full article
Fucoidan and Lung Function: Value in Viral Infection, Marine Drugs, 2021
A review paper discussing recent research into the potential for Maritech® fucoidan in limiting lung damage that is often caused by respiratory viral infections. + full article
Incorporation of FGF-2 into Pharmaceutical Grade Fucoidan/Chitosan Polyelectrolyte Multilayers, Marine Drugs, 2020
Fucoidan highlighted as a promising candidate for the development of new materials for use in the medical device sector. + full article
Fucoidan Supplementation Restores Fecal Lysozyme Concentrations in High-Performance Athletes: A Pilot Study, Marine Drugs, 2020
Maritech® fucoidan has been shown to restore the secretion of anti-microbial peptides and contribute to the regulation of mucosal immune health in elite athletes. + full article
Oral Fucoidan Attenuates Lung Pathology and Clinical Signs in a Severe Influenza A Mouse Model. Marine Drugs, 2020
Australian and UK researchers have demonstrated that Maritech® fucoidan is effective in significantly reducing clinical symptoms and lung damage in a severe Influenza A H1N1 model. + full article
MicroRNA Expression after Ingestion of Fucoidan; A Clinical Study. Marine Drugs, 2020
An Australian clinical study, co-authored by members of Marinova's research team, reveals that an extract from the seaweed Undaria pinnatifida influences over 30 different biological pathways and processes. + full article
Lysozyme uptake into pharmaceutical grade fucoidan/chitosan polyelectrolyte multilayers under physiological conditions. Journal of Colloid and Interface Science, 2020
An examination of polyelectrolyte multilayers (PEMs) demonstrating that fucoidan is a promising candidate for the development of new materials in the medical device sector. + full article
Therapies from Fucoidan: New Developments. Marine Drugs, 2019
The third comprehensive fucoidan review published by Marinova’s Chief Scientist, Dr Helen Fitton. This review explains the recent use of fucoidan to treat renal disease, the radiolabelling of blood clots, and the increased use of fucoidan in commercially available supplements and topical treatments. + full article
The manufacture, characterization, and uses of fucoidans from macroalgae, 2019
A comprehensive chapter prepared by Marinova’s research team and published in Enzymatic technologies for marine polysaccharides edited by Antonio Trincone. + full article
Pathway Analysis of Fucoidan Activity Using a Yeast Gene Deletion Library Screen. Marine Drugs, 2019
Outcomes of the first study to screen fucoidan against a gene library to investigate all possible pathways of action. Maritech® fucoidan was shown to work selectively against cancer cells but not against normal, healthy cells that were used as a control.+ full article
Odd-even effects on hydration of natural polyelectrolyte multilayers: An in situ synchrotron FTIR microspectroscopy study. Journal of Colloid and Interface Science, 2019
Odd-even effects in polysaccharide polyelectrolyte multilayers influence their hydration content and the chemical environment of the water within them. + full article
Comparative study on neuroprotective activities of fucoidans from Fucus vesiculosus and Undaria pinnatifida. International Journal of Biological Macromolecules, 2019
This study investigated the neuroprotective activities of five different fucoidan samples with different chemical compositions prepared from Fucus vesiculosus (FE, FF, and S) and Undaria pinnatifida (UE and UF) to determine if they reduced aggregation or cytotoxicity of Aβ1–42 in neuronal PC-12 cells. + full article
The Effect of Undaria pinnatifida Fucoidan on the Pharmacokinetics of Letrozole and Tamoxifen in Patients With Breast Cancer. Integr Cancer Ther. 2018
No significant changes in steady-state plasma concentrations of letrozole, tamoxifen, or tamoxifen metabolites were detected after co-administration with fucoidan. In addition, no adverse effects of fucoidan were reported, and toxicity monitoring showed no significant differences in all parameters measured over the study period. + full article
Electrochemical behaviour at a liquid-organogel microinterface array of fucoidan extracted from algae. Analyst, 2017
An assessment of the electrochemical behaviour of fucoidans extracted from two algal species, Undaria pinnatifida and Fucus vesiculosus. + full article
The influence of polyanion molecular weight on polyelectrolyte multilayers at surfaces: protein adsorption and protein–polysaccharide complexation/stripping on natural polysaccharide films on solid supports. Physical Chemistry Chemical Physics, 2017
Two different fucoidan polymers were used to create substrates for protein adsorption studies. + full article
Effects of fucoidan from Fucus vesiculosus in reducing symptoms of osteoarthritis: a randomized placebo-controlled trial. Biologics, 2016
A clinical investigation demonstrating that Fucus vesiculosus fucoidan extract was safe and well tolerated. + full article
Quantitative determination of fucoidan using polyion-sensitive membrane electrodes. Analytica Chimica Acta, 2015
The use of polyanion and polycation-sensitive membrane electrodes to detect five different preparations of fucoidan is described. + full article
In Situ ATR FTIR Spectroscopic Study of the Formation and Hydration of a Fucoidan/Chitosan Polyelectrolyte Multilayer. Langmuir, 2015
The formation of fucoidan/chitosan-based polyelectrolyte multilayers (PEMs) has been studied with in situ Fourier transform infrared (FTIR) spectroscopy. + full article
Therapies from Fucoidan: An Update. Marine Drugs, 2015
An updated review of existing research findings on fucoidan, written by Marinova’s Chief Scientist, Dr Helen Fitton. This review discusses the main bioactivities and application areas of fucoidan, as well as characterisation, extraction and detection methods for fucoidan compounds. Full article
Fucoidan Extracts Ameliorate Acute Colitis. PLOS ONE, 2015
This research paper highlights the benefits of oral Maritech® Fucus vesiculosus fucoidan and Maritech® Synergy in a mouse model of acute colitis. Cumulative histological disease scores for the distal colon and weight loss – a common and often undesirable side effect of colitis – were significantly reduced. + full article
Fucoidans Disrupt Adherence of Helicobacter pylori to AGS Cells In Vitro. Evidence Based Complementary and Alternative Medicine, 2015
The in vitro studies discussed in this paper show Maritech® fucoidan extracts are extremely effective at dislodging H. pylori from infected human gastric cells. The study also shows fucoidan extracts inhibit human gastric cancer cells in vitro. Full article
Topical Benefits of Two Fucoidan-Rich Extracts from Marine Macroalgae. Cosmetics, 2015
This comprehensive research paper discusses a variety of clinical and in vitro studies that attest to the profound cosmetic bioactivity of Maritech® Bright and Maritech® Reverse. These qualities include anti-ageing, protecting and soothing following UV exposure and skin brightening. Full article
Tuning polyelectrolyte multilayer structure by exploiting natural variation in fucoidan chemistry. Soft Matter, 2015
Distinct differences were observed between multilayers formed with two different fucoidans from two different seaweed species. + full article
A fucose containing polymer-rich fraction from the brown alga Ascophyllum nodosum mediates lifespan increase and thermal-tolerance in Caenorhabditis elegans, by differential effects on gene and protein expression. Food Funct. 2015
An Ascophyllum nodosum fucose-containing polymer (FCP) significantly improved the life span and tolerance against thermally induced stress in C. elegans. + full article
Therapies from Fucoidan; Multifunctional Marine Polymers. Marine Drugs, 2011
The first review paper written on fucoidan by Marinova’s Chief Scientist, Dr Helen Fitton. It provides an elaborate guide on fucoidan research undertaken between 2000 and 2010 and created a foundation for the subsequent review papers published in 2015 and 2019 + full article
Formation of an adherent hematopoietic expansion culture using fucoidan. Annals of Hematology, 2011
Characterizing the effect on hematopoietic cell culture of fucoidan. + full article
A combined Phase I and II open-label study on the immunomodulatory effects of seaweed extract nutrient complex. Biologics, 2011
This article provides clinical evidence to confirm the safety of oral fucoidan administration. Fucoidan significantly increased cytotoxic T cells and phagocytic capacity in monocytes, as well as significantly decreasing levels of inflammatory cytokine Interleukin-6. Full article
A combined phase I and II open-label study on the effects of seaweed extract nutrient complex on osteoarthritis. Biologics, 2010
Osteoarthritis symptoms decreased in a dose-dependent manner, when human subjects suffering from clinical diagnosed osteoarthritis were supplemented with oral fucoidan. This study also confirms the safety of oral Maritech® fucoidan consumed at a high dose over a 12 week period. Full article
Pilot clinical study to evaluate the anticoagulant activity of fucoidan. Blood Coagul Fibrinolysis, 2009
This pilot clinical trial aimed to assess the safety and clinical effects of fucoidan ingestion on hemostasis. + full article
Fucoidan ingestion increases the expression of CXCR4 on human CD34+ cells. Experimental Hematology, 2007
This research paper elaborates on the ability of Maritech® fucoidan to increase stem cell populations. The clinical trial found oral administration of Maritech® Undaria pinnatifida fucoidan significantly increased the CXCR4 hemopoietic stem cell population, from 45% to 90% after only 12 days. + full article
Macroalgal Fucoidan Extracts: A New Opportunity for Marine Cosmetics. Cosmetics and Toiletries, 2007
An exploration of the bioactivity and historical applications of macroalgae with a particular focus on fucoidan. + full article
Marine Algae and Polysaccharides with Therapeutic Applications, 2007
A chapter within Marine nutraceuticals and functional foods (pp.345-366) published by CRC Press + full article
A quantitative method to detect fucoidan in human plasma using a novel antibody. Methods Find Exp Clin Pharmacol, 2005
An antibody-based method to assess plasma uptake of a proprietary Undaria-derived fucoidan galactofucan sulfate (GFS(TM)) after oral ingestion by human volunteers. + full article
Antiviral activity of Undaria pinnatifida against Herpes Simplex Virus. Phytotherapy Research, 2004
This paper presents in vitro studies on the activity of fucoidan towards various clinical strains of the Herpes Simplex virus. Maritech® Undaria pinnatifida fucoidan was found to exhibit excellent anti-viral activity, through the inhibition of viral binding and entry to host cells. + full article
Brown Marine Algae: A Survey of Therapeutic Potentials. Alternative and Complementary Therapies, 2004
An overview of the potential therapeutic benefits of fucoidan. + full article